Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

CEPI and WBVR partner on vaccine for Rift Valley fever

July 12, 2019

New vaccine protects nonhuman primates against equine encephalitis viruses

July 11, 2019

New malaria vaccine successfully tested on Rhesus macaques

July 10, 2019

Pediatric registrational trial of rivogenlecleucel meets primary endpoint

July 9, 2019

FDA approves Xembify for primary immunodeficiencies

July 5, 2019

Gut microbiome affects food allergies

July 5, 2019

Danish Medicines Agency approves AJ Vaccines' polio vaccine

July 1, 2019

Vedanta's live biotherapeutic product candidate VE-416 begins phase Ib/II study for peanut allergy

July 1, 2019

Initiation of pivotal phase III clinical trial of mavorixafor for the treatment of WHIM syndrome

June 27, 2019

Norovirus' bright side

June 20, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...